Non-Melanocytic Skin Cancers of the Head and Neck: A Clinical Study in Jeju Province

Abstract

BackgroundJeju Island is geographically and socioeconomically distinct from the mainland of South Korea. Thus, the presentation and management of non-melanocytic skin cancers (NMSC) of the head and neck may differ from those in other regions of the country. We compared the clinical characteristics and treatment modalities of NMSC on Jeju Island with the findings of similar regional studies. MethodsPatient data, including age, sex, diagnosis, tumor site, treatment, and recurrence, were obtained from the medical and pathology records of patients diagnosed with NMSC between January 2010 and June 2015. ResultsIn total, 190 patients (57 men) with a mean age of 75 years (range, 42–97) were assessed. Overall, 203 NMSCs were diagnosed, including 123 basal cell carcinomas and 80 squamous cell carcinomas. The tumor sites included the nose, cheeks, periorbital area, and lips (n=55, 54, 25, and 20, respectively). We identified 92 T1-stage and 60 T2-stage tumors, and 120 cases were treated with wide surgical resection and 17 cases were treated with radiation therapy at the medical center. Of the 120 cases treated surgically, 69 required reconstructive surgery using a local skin flap, 22 required full-thickness skin grafting, and 12 underwent primary closure. Basal and squamous cell carcinomas recurred in 2 and 1 cases, respectively. ConclusionsCompared to the reports from other regions, the average patient age was 10 years higher, with a marked female preponderance. While the proportion of squamous cell carcinoma was higher than in other regions, the tumor distribution and surgical management profiles were similar.

Effectiveness of radiotherapy for head and neck skin cancers: a single-institution study

“…Our 3-year LFFS rate was 91.7% ( Fig. 1), which was similar to that previously reported for radiotherapy [8] and comparable to data regarding the surgical treatment of basal and squamous cell skin cancers in the head and neck region [18]. Treatment options for BCC and SCC skin cancers in the head and neck region include surgical excision and radiotherapy.…”

“…Cosmetic outcomes were mostly excellent or good. Kang et al [18] reported 120 patients with BCC or SCC of the face treated with surgery, obtaining a 98% local control rate.…”

The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study

“…SCC, the second recorded common NMSC, is of keratinocyte origin. 9 It involves the trunk and other body parts 10 and is mainly categorized histologically as well, moderately or poorly differentiated. 11 …”

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas

“…Their combination may increase long term efficacy and reduce surgical removal, especially on sun exposed areas, with excellent cosmetic results, increasing patient's compliance (Cantisani et al, 2012;Micali et al, 2014). Recent studies have suggested an increased incidence of NMSC in women (Kang, Yun, Song, & Shin, 2017). This could be attributed to women's increasing longer average life expectancy and the consequent increased exposure to UV rays.…”